Free, and Not Total, 1,25-Dihydroxyvitamin D Regulates 25-Hydroxyvitamin D Metabolism by Keratinocytes
- 1 February 1989
- journal article
- research article
- Published by The Endocrine Society in Endocrinology
- Vol. 124 (2) , 649-654
- https://doi.org/10.1210/endo-124-2-649
Abstract
Greater than 99% of the total circulating 1,25-dihydroxyvitamin D-[1,25-(OH)2D] is bound to proteins such as the vitamin D-binding protein (DBP) and albumin; in the normal human only 0.4% of the circulating 1,25-(OH)2D is free. Although it is often assumed that only the free concentration of 1,25-(OH)2D is available to cells, this has not been demonstrated. In particular, it is not clear whether the DBPs facilitate 1,25-(OH)2D entry into target cells or serve only to transport these metabolites within the circulation. To address this question, we evaluated one of the best characterized target tissue responses to 1,25-(OH)2D, namely its ability to inhibit its own production and induce that of 24,25-(OH)2D, using one of the most sensitive cells, the human foreskin keratinocyte. We incubated keratinocytes in the presence of 1,25-(OH)2D (from 10-11 -10-8 M) in medium containing albumin (from 0.1-10%) or serum (from 0.1-10%) for 4 h [to inhibit the 25-hydroxyvitamin D (250HD) 1.alpha.-hydroxylase] or 16 h (to induce the 250HD 24-hydroxylase) before evaluating [3H]250HD metabolism by these cells during a 1-h incubation in serum- and albumin-free medium. The free fraction of 1,25-(OH)2D was determined in each medium by centrifugal ultrafiltration and varied from 36% to 0.57% in direct proportion to the albumin or serum in the medium. Increasing the serum or albumin concentration in the medium increased the concentration of total 1,25-(OH)2D needed to inhibit its own production or stimulate that of 24,25-(OH)2D. In contrast, the concentration of free 1,25-(OH)2D needed to half-maximally inhibit its own production or induce 24,25-(OH)2D production remained constant at approximately 10-11 M. We conclude that the free, not the total, 1,25-(OH)2D concentration regulates 250HD metabolism by keratinocytes, that DBPs do not facilitate 1,25-(OH)2D.This publication has 10 references indexed in Scilit:
- Biochemical and morphological characterization of growth and differentiation of normal human neonatal keratinocytes in a serum‐free mediumJournal of Cellular Physiology, 1988
- Detection of Vitamin D Binding Protein on the Surface of Cytotrophoblasts Isolated from Human Placentae*Endocrinology, 1987
- Free 25-hydroxyvitamin D levels are normal in subjects with liver disease and reduced total 25-hydroxyvitamin D levels.Journal of Clinical Investigation, 1986
- 1,25-Dihydroxyvitamin D3 production by human keratinocytes. Kinetics and regulation.Journal of Clinical Investigation, 1986
- Serum Protein Binding of 1,25-Dihydroxyvitamin D: A Reevaluation by Direct Measurement of Free Metabolite Levels*Journal of Clinical Endocrinology & Metabolism, 1985
- Free 1,25-dihydroxyvitamin D levels in serum from normal subjects, pregnant subjects, and subjects with liver disease.Journal of Clinical Investigation, 1984
- Human serum binding protein for vitamin D and its metabolites (DBP): Evidence that actin is the DBP binding component in human skeletal muscleArchives of Biochemistry and Biophysics, 1982
- Influence of the Vitamin D-binding Protein on the Serum Concentration of 1,25-Dihydroxyvitamin D3Journal of Clinical Investigation, 1981
- Transport of vitamin D sterols in human plasma: effect of excess vitamin D, 25 hydroxyvitamin D and 1,25 dihydroxyvitamin DEuropean Journal of Clinical Investigation, 1979
- Effect of oestrogen and 1,25-dihydroxycholecalciferol on 25-hydroxycholecalciferol metabolism in primary chick kidney-cell culturesBiochemical Journal, 1978